The assays, like RNA pull-down in lung, gastric, and colorectal cancers, involve BC-IMPAD, NEAT1/miR-17-5p/TGFβR2, and FENDRR-GSTP1, respectively [51]. This evidence concerns the gene TGFBR2 and breast cancer.